Lumos Pharma, Inc.
USD4.34
+0.00 (+0.00%)
CEO
Richard J. Hawkins
IPO Date
2011-11-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.33
Prev. Close
$4.34
Day Low
$4.33
Day High
$4.34
52W Low
$1.37
52W High
$4.58
Market Cap
$0.04B
Volume
0.39M
| -1.0 |
| 31 Dec 2021 | FY | 100.0% | -13230.4% | -34.2% | -30.3% | 0.01 | 19.43 | -1.9 |
| 31 Dec 2020 | FY | 100.0% | -3370.8% | -4.9% | -4.4% | 0.00 | 19.88 | -42.7 |
| 31 Dec 2019 | FY | 96.0% | -4592.8% | -54.5% | -44.4% | 0.02 | 7.98 | -2.2 |
| 31 Dec 2018 | FY | 1034.3% | -4444.0% | -46.5% | -40.9% | 0.00 | 14.36 | -1.1 |
| 31 Dec 2017 | FY | -260.8% | -18449.0% | -47.5% | -39.8% | 0.00 | 7.96 | -3.5 |
| 31 Dec 2016 | FY | 100.0% | -2415.1% | -65.8% | -48.7% | 0.00 | 4.43 | -3.5 |
| 31 Dec 2015 | FY | 189.5% | -111.7% | -20.6% | -18.5% | 0.00 | 14.03 | -25.8 |
| 31 Dec 2014 | FY | 104.0% | 62.0% | 50.5% | 43.2% | 0.00 | 9.18 | 10.8 |
| -0.6 |
| 31 Mar 2024 | Q1 | 98.8% | -6327.9% | -59.9% | -37.2% | 0.03 | 6.24 | -0.6 |
| 31 Dec 2023 | Q4 | 97.8% | -1144.9% | -34.6% | -23.3% | 0.24 | 5.69 | -0.7 |
| 30 Sept 2023 | Q3 | -14.3% | -118571.4% | -23.4% | -17.4% | 0.01 | 7.76 | -0.8 |
| 30 Jun 2023 | Q2 | 98.3% | -1694.7% | -20.5% | -15.8% | 0.01 | 8.55 | -0.8 |
| 31 Mar 2023 | Q1 | 98.7% | -963.4% | -12.7% | -10.4% | 0.01 | 12.61 | -1.0 |
| 31 Dec 2022 | Q4 | 93.2% | -1498.4% | -12.9% | -10.6% | 0.00 | 10.73 | -1.0 |
| 30 Sept 2022 | Q3 | 100.0% | -1459.0% | -10.7% | -9.2% | 0.00 | 14.38 | -2.6 |
| 30 Jun 2022 | Q2 | 100.0% | -1926.6% | -10.4% | -9.1% | 0.01 | 17.59 | -2.1 |